Medical Gas and Equipment Market

Executive Summary

Medical Gas and Equipment Market was valued at US $2,822.17 million in 2021 and is projected to grow at 7.05% CAGR over the forecast period to reach US $4,247.27 million by 2027. Medical Gas and Equipment Market represented US $359.49 million opportunity over 2019-2021 and estimated to create US $1,425.10 million opportunity in 2027 over 2021.

Medical Gas and Equipment from Consainsights analyses the Medical Gas and Equipment Market in the Life Sciences industry over the forecast period to 2027.

Medical Gas and Equipment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Gas and Equipment segmentation includes Type, Application, End User, Region and Geography.

Based on the Type, the Medical Gas and Equipment analysis covers Medical Gases, Medical Gas Equipment.

In Type segment, Medical Gases segment has highest cagr growth of 6.24%.

Based on the Application, the Medical Gas and Equipment analysis covers Therapeutic Applications, Pharmaceutical Manufacturing & Research, Diagnostic Applications, Other Applications.

In Application segment, Therapeutic Applications segment has highest cagr growth of 6.24%.

Based on the End User, the Medical Gas and Equipment analysis covers Hospitals, Home Healthcare, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Emergency Services.

In End User segment, Hospitals segment has highest cagr growth of 6.24%.

Based on the Region, the Medical Gas and Equipment analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

In Region segment, North America segment has highest cagr growth of 6.24%.

Based on the region, the Medical Gas and Equipment analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Air Liquide, The Linde Group, Air Products and Chemicals, Inc., Praxair, Inc., Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.), Atlas Copco AB, Gce Holding AB, Messer Group GmbH, SOL SPA, Rotarex S.A., Additional Company Profiles and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Medical Gases segment has the highest revenue of US $2,206.68 million and is expected to grow at CAGR of 6.24% by 2027 Medical Gases segment has highest cagr growth of 6.24%.

Medical Gases

Medical Gases segment was valued at US $1,925.59 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $3,320.98 million by 2027. Medical Gases segment represented US $281.09 million opportunity over 2019-2021 and estimated to create US $1,114.30 million opportunity in 2027 over 2021.

Medical Gas Equipment

Medical Gas Equipment segment was valued at US $537.09 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $926.29 million by 2027. Medical Gas Equipment segment represented US $78.40 million opportunity over 2019-2021 and estimated to create US $310.80 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Therapeutic Applications segment has the highest revenue of US $1,197.17 million and is expected to grow at CAGR of 6.24% by 2027 Therapeutic Applications segment has highest cagr growth of 6.24%.

Therapeutic Applications

Therapeutic Applications segment was valued at US $1,044.67 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,801.70 million by 2027. Therapeutic Applications segment represented US $152.50 million opportunity over 2019-2021 and estimated to create US $604.53 million opportunity in 2027 over 2021.

Pharmaceutical Manufacturing & Research

Pharmaceutical Manufacturing & Research segment was valued at US $919.30 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,585.48 million by 2027. Pharmaceutical Manufacturing & Research segment represented US $134.20 million opportunity over 2019-2021 and estimated to create US $531.98 million opportunity in 2027 over 2021.

Diagnostic Applications

Diagnostic Applications segment was valued at US $493.09 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $850.41 million by 2027. Diagnostic Applications segment represented US $71.98 million opportunity over 2019-2021 and estimated to create US $285.34 million opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $5.61 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $9.68 million by 2027. Other Applications segment represented US $0.82 million opportunity over 2019-2021 and estimated to create US $3.25 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $1,195.85 million and is expected to grow at CAGR of 6.24% by 2027 Hospitals segment has highest cagr growth of 6.24%.

Hospitals

Hospitals segment was valued at US $1,043.52 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,799.72 million by 2027. Hospitals segment represented US $152.33 million opportunity over 2019-2021 and estimated to create US $603.87 million opportunity in 2027 over 2021.

Home Healthcare

Home Healthcare segment was valued at US $594.93 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,026.04 million by 2027. Home Healthcare segment represented US $86.85 million opportunity over 2019-2021 and estimated to create US $344.27 million opportunity in 2027 over 2021.

Pharmaceutical & Biotechnology Companies

Pharmaceutical & Biotechnology Companies segment was valued at US $285.87 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $493.03 million by 2027. Pharmaceutical & Biotechnology Companies segment represented US $41.73 million opportunity over 2019-2021 and estimated to create US $165.43 million opportunity in 2027 over 2021.

Academic & Research Institutions

Academic & Research Institutions segment was valued at US $325.94 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $562.13 million by 2027. Academic & Research Institutions segment represented US $47.58 million opportunity over 2019-2021 and estimated to create US $188.61 million opportunity in 2027 over 2021.

Emergency Services

Emergency Services segment was valued at US $212.41 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $366.34 million by 2027. Emergency Services segment represented US $31.01 million opportunity over 2019-2021 and estimated to create US $122.92 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $1,293.54 million and is expected to grow at CAGR of 6.24% by 2027 North America segment has highest cagr growth of 6.24%.

North America

North America segment was valued at US $1,128.77 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,946.74 million by 2027. North America segment represented US $164.77 million opportunity over 2019-2021 and estimated to create US $653.20 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $631.06 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $1,088.36 million by 2027. Europe segment represented US $92.12 million opportunity over 2019-2021 and estimated to create US $365.18 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $415.61 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $716.78 million by 2027. Asia Pacific segment represented US $60.67 million opportunity over 2019-2021 and estimated to create US $240.50 million opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $176.54 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $304.47 million by 2027. Latin America segment represented US $25.77 million opportunity over 2019-2021 and estimated to create US $102.16 million opportunity in 2027 over 2021.

Middle East and Africa

Middle East and Africa segment was valued at US $110.70 million in 2019 and is projected to grow at 6.24% CAGR over the forecast period to reach US $190.91 million by 2027. Middle East and Africa segment represented US $16.16 million opportunity over 2019-2021 and estimated to create US $64.06 million opportunity in 2027 over 2021.